What guidance did NextPlat's management provide for the next earnings period?

What were the key takeaways from NextPlat's earnings call?

What is the market's earnings forecast for NextPlat next quarter?

What is the revenue and EPS growth rate for NextPlat year over year?

What is NextPlat's gross profit margin?

What were the key takeaways from NextPlat’s earnings call?

What factors drove the changes in NextPlat's revenue and profit?

What is NextPlat's latest dividend and current dividend yield?

- **Revenue decline**: Q3 2025 revenue $13.8M (-11% YoY), driven by healthcare segment underperformance
- **Cost savings success**: Operating expenses down 40% to $4.7M, including $800K salary cuts
- **340B business rebound**: October 340B revenue up 140% MoM, 1,600+ prescriptions
- **Growth opportunities**: 
  - 27% QoQ increase in retail prescriptions
  - Florida Sunshine nutraceuticals launching in China
  - 2026 operational break-even target
- **Risks**: Ongoing lawsuits and China regulatory delays

**【CEO Summary Section】**
- Q3 2025 revenue of $13.8M (-11% YoY) reflects ongoing operational challenges, with healthcare segment revenue down $1.5M and e-commerce down $100K.
- Key improvements: 
  - 340B contract revenue increased 140% MoM in October (1,600+ prescriptions vs. prior lows)
  - Retail prescription volumes up 27% QoQ
  - $1.5M one-time inventory cost savings
- 2026 goals: Achieve operational break-even by mid-2026 through cost-cutting and new contracts in healthcare and communications
- New initiatives: 
  - Florida Sunshine nutraceuticals launched in UK/EU
  - AI-driven marketing campaign for Opco products in China
  - 340B business expansion with returning clients

**【CFO Financial Commentary】**
- **Revenue**: $13.8M (Q3 2025) vs. $15.4M (Q3 2024)
- **Gross Margin**: 19.9% (Q3 2025) vs. 23.2% (Q3 2024)
- **Operating Expenses**: $4.7M (-40% YoY) due to:
  - Salaries down $800K (executive cuts, leaner workforce)
  - Professional fees down $1.8M (legal/consulting reductions)
- **Liquidity**: $13.9M cash, $18.9M working capital
- **Share Buybacks**: 130,549 shares repurchased under authorized program

**【Q&A Key Highlights】**
1. **Share Buybacks**: Program remains active but constrained by need to invest in growth initiatives
2. **NASDAQ Compliance**: 180-day extension to regain compliance; focus on financial performance
3. **China Strategy**: 
  - Opco products show strong margins despite tariffs
  - Florida Sunshine Tmall store launching soon
4. **Legal Matters**: Two lawsuits resolved; final matter under review

Nextplat Corp (NXPL) Q3 2025 Earnings Call Transcript

- **Revenue decline driven by healthcare**: Q1 2025 revenue down 17.7% to $14.5M, with 340B contract losses and pharmacy reimbursement pressures
- **Tariff challenges limiting growth**: Florida Sunshine China launch delayed due to 25%+ tariffs; exploring UK alternative
- **Strategic pivot to high-margin businesses**: Shifting healthcare to 340B contracts; e-commerce focusing on tariff-free IoT services
- **Cash position stable**: $17.7M cash balance despite cost reductions
- **NASDAQ compliance at risk**: 12-month timeline to meet $1 bid price; no buyback activity expected near-term

**【CEO Opening Remarks】**
- Q1 2025 revenue declined 17.7% YoY to $14.5M, driven by healthcare segment contraction and e-commerce headwinds.
- Key challenges: 
  - Tariffs on Florida Sunshine products in China delaying launch
  - 340B pharmacy contract losses
  - Retail pharmacy reimbursement pressures
- Strategic initiatives: 
  - Exploring sale/merger of underperforming assets
  - Shifting healthcare focus to high-margin 340B contracts
  - Diversifying e-commerce into tariff-free IoT services

**【CFO Financial Review】**
- Healthcare segment revenue down 20% due to:
  - 340B contract terminations
  - Prescription volume decline
  - In-house pharmacy openings
- E-commerce gross margin pressured by:
  - Expired airtime contract costs
  - Tariff-related hardware sales decline
- Operating expenses reduced 10% via:
  - Elimination of non-recurring costs
  - Vendor contract renegotiations
- Cash balance remains stable at $17.7M

**【Global Ops CEO Update】**
- Communications business outperforms with:
  - 51% growth in high-margin IoT airtime
  - Tariff-free recurring revenue
- Florida Sunshine challenges:
  - 25%+ tariffs make China launch unprofitable
  - Exploring UK market alternative
- OPKO products show promise:
  - Largest-ever China shipment
  - Physical retail pilot program

**【Q&A Key Takeaways】**
- Share buyback on hold due to:
  - Blackout periods
  - Material info restrictions
- NASDAQ compliance plan:
  - 12-month timeline to meet $1 bid price
  - Focused on strategic actions to drive value
- Litigation: No updates provided


Actual												-0.22				-0.08
Forecast	0									0	0		0	0
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Actual	--	--	--	--	--	--	--	--	--	--	--	15.37M	--	--	--	13.75M	--
Forecast	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

NXPL

NXPL fundamentals

NXPL Q4 2025 Earnings Preview

Earnings Call

You can ask Aime

NXPL

NXPL fundamentals

NXPL Q4 2025 Earnings Preview

Earnings Call

NXPL Earnings Call Summary for Q4/2025Upcoming8:30 AM on Mar 31, 2026

NXPL Earnings Call Summary for Q3/20258:30 AM on Nov 13, 2025

NXPL Earnings Call Summary for Q2/20258:30 AM on Aug 14, 2025

NXPL Earnings Call Summary for Q1/20258:30 AM on May 15, 2025

NXPL Earnings Call Summary for Q4/2024 Mar 28, 2026

You can ask Aime